Form D · Pharmaceuticals
BELLICUM PHARMACEUTICALS, INC
Houston, TX · CIK 0001358403
Offering snapshot reported Sep 3, 2014 · SEC filing
- Reported sold
- $94.4M Offering amount: $94.4M
- Investors reported
- 76 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 22, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 3, 2014 | Initial | $94,357,588 | No comparison | 76 | SEC filing |
| Oct 16, 2013 | Amendment | $19,649,134 | -$240,669vs Mar 22, 2012 | 21 | SEC filing |
| Mar 22, 2012 | Initial | $19,889,803 | No comparison | 21 | SEC filing |
| Oct 25, 2010 | Initial | $1,175,000 | No comparison | 10 | SEC filing |
| Oct 21, 2009 | Initial | $1,250,000 | No comparison | 17 | SEC filing |
| Mar 31, 2009 | Initial | $500,000 | No comparison | Not reported | SEC filing |
| Jul 29, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 23, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $3.14M
- Finders' fees
- $0
- Form D file number
- 021-224038
The Total Offering Amount and Total Amount Sold includes $39,357,588 that may be received by the Issuer upon exercise of the warrants.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Jefferies LLC | 2347 |
Source: Form D, filed Sep 3, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James F. Brown | Director |
| Thomas J. Farrell | Director, Executive |
| Frank Mc Guyer | Director |
| Ken Moseley | Executive |
| Annemarie Moseley | Executive |
| Joseph Senesac | Executive |
| Kevin M. Slawin | Director |
| David M. Spencer | Executive |
| Dennis K. Stone | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2130 West Holcombe Boulevard Suite 850
Houston, TX, 77030
Houston, TX, 77030